相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Metabolic adverse effects of off-label use of second-generation antipsychotics in the adult population: a systematic review and meta-analysis
Nicolette Stogios et al.
NEUROPSYCHOPHARMACOLOGY (2022)
Clinical audit of cardio-metabolic monitoring in people with intellectual disability (PWID) taking antipsychotic medication
Sandar Kyaw et al.
BJPSYCH OPEN (2021)
Second generation antipsychotic-induced weight gain in youth with autism spectrum disorders: a brief review of mechanisms, monitoring practices, and indicated treatments
Jeffrey Goltz et al.
INTERNATIONAL JOURNAL OF DEVELOPMENTAL DISABILITIES (2021)
Preventing and Treating Diabetes in Canadian Adults With Intellectual and Developmental Disabilities
Brianne Redquest et al.
CANADIAN JOURNAL OF DIABETES (2020)
Obesity in adults: a clinical practice guideline
Sean Wharton et al.
CANADIAN MEDICAL ASSOCIATION JOURNAL (2020)
Metabolic syndrome and its components in people with intellectual disability: a meta-analysis
D. Vancampfort et al.
JOURNAL OF INTELLECTUAL DISABILITY RESEARCH (2020)
Leisure-time physical activity and all-cause mortality among adults with intellectual disability: the National Health Interview Survey
K. M. Diaz
JOURNAL OF INTELLECTUAL DISABILITY RESEARCH (2020)
Is fatness or fitness key for survival in older adults with intellectual disabilities?
Alyt Oppewal et al.
JOURNAL OF APPLIED RESEARCH IN INTELLECTUAL DISABILITIES (2020)
Metformin in 2019
James Flory et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2019)
Multimorbidity and lifestyle factors among adults with intellectual disabilities: a cross-sectional analysis of a UK cohort
F. Tyrer et al.
JOURNAL OF INTELLECTUAL DISABILITY RESEARCH (2019)
Antipsychotic Use With and Without Comorbid Psychiatric Diagnosis Among Adults with Intellectual and Developmental Disabilities
Yona Lunsky et al.
CANADIAN JOURNAL OF PSYCHIATRY-REVUE CANADIENNE DE PSYCHIATRIE (2018)
Lifestyle Approaches for People With Intellectual Disabilities: A Systematic Multiple Case Analysis
Henderika Annegien Steenbergen et al.
JOURNAL OF THE AMERICAN MEDICAL DIRECTORS ASSOCIATION (2017)
BAP guidelines on the management of weight gain, metabolic disturbances and cardiovascular risk associated with psychosis and antipsychotic drug treatment
Stephen J. Cooper et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2016)
Metformin for Treatment of Overweight Induced by Atypical Antipsychotic Medication in Young People With Autism Spectrum Disorder A Randomized Clinical Trial
Evdokia Anagnostou et al.
JAMA PSYCHIATRY (2016)
Mortality of People with Intellectual Disabilities in England: A Comparison of Data from Existing Sources
Pauline Heslop et al.
JOURNAL OF APPLIED RESEARCH IN INTELLECTUAL DISABILITIES (2015)
Mortality among a Cohort of Persons with an Intellectual Disability in New South Wales, Australia
Tony Florio et al.
JOURNAL OF APPLIED RESEARCH IN INTELLECTUAL DISABILITIES (2015)
Monitoring metabolic side effects of atypical antipsychotics in people with an intellectual disability
Sadira Teeluckdharry et al.
JOURNAL OF INTELLECTUAL DISABILITIES (2013)
Weight Gain and Metabolic Risks Associated with Antipsychotic Medications in Children and Adolescents
Lawrence Maayan et al.
JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY (2011)
Effects of a 10-week weight control program on obese patients with schizophrenia or schizoaffective disorder: A 12-month follow up
Chih-Ken Chen et al.
PSYCHIATRY AND CLINICAL NEUROSCIENCES (2009)
Metformin ameliorates treatment of obese type 2 diabetic patients with mental retardation; its effects on eating behavior and serum leptin levels
T Komori et al.
EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES (2004)
Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin
WC Knowler et al.
NEW ENGLAND JOURNAL OF MEDICINE (2002)
Cardiovascular fitness and body composition of youth with and without mental retardation
KH Pitetti et al.
ADAPTED PHYSICAL ACTIVITY QUARTERLY (2001)
分享论文
